Issue 91, 2021

Metal–organic frameworks (MOFs) as host materials for the enhanced delivery of biomacromolecular therapeutics

Abstract

Biomacromolecular drugs have become an important class of therapeutic agents for the treatment of human diseases. Considering their high propensity for being degraded in the human body, the choice of an appropriate delivery system is key to ensure the therapeutic efficacy of biomacromolecular drugs in vivo. As an emerging class of supramolecular “host” materials, metal–organic frameworks (MOFs) exhibit advantages in terms of the tunability of pore size, encapsulation efficiency, controllable drug release, simplicity in surface functionalization and good biocompatibility. As a result, MOF-based host–guest systems have been extensively developed as a new class of flexible and powerful platform for the delivery of therapeutic biomacromolecules. In this review, we summarize current research progress in the synthesis of MOFs as delivery materials for a variety of biomacromolecules. Firstly, we briefly introduce the advances made in the use of biomacromolecular drugs for disease therapy and the types of commonly used clinical delivery systems. We then describe the advantages of using MOFs as delivery materials. Secondly, the strategies for the construction of MOF-encapsulated biomacromolecules (Biomacromolecules@MOFs) and the release mechanisms of the therapeutics are categorized. Thirdly, the application of MOFs to deliver different types of biomacromolecules (e.g., antigens/antibodies, enzymes, therapeutic proteins, DNA/RNA, polypeptides, and polysaccharides) for the treatment of various human diseases based on immunotherapy, gene therapy, starvation therapy and oxidation therapy is summarized. Finally, the remaining challenges and available opportunities for MOFs as drug delivery systems are outlined, which we anticipate will encourage additional research efforts directed towards developing Biomacromolecules@MOFs systems for biomedical applications.

Graphical abstract: Metal–organic frameworks (MOFs) as host materials for the enhanced delivery of biomacromolecular therapeutics

Article information

Article type
Feature Article
Submitted
13 sen 2021
Accepted
27 sen 2021
First published
27 sen 2021
This article is Open Access
Creative Commons BY license

Chem. Commun., 2021,57, 12098-12110

Metal–organic frameworks (MOFs) as host materials for the enhanced delivery of biomacromolecular therapeutics

P. Tong, L. Zhu, Y. Zang, J. Li, X. He and T. D. James, Chem. Commun., 2021, 57, 12098 DOI: 10.1039/D1CC05157A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements